Crewe Advisors LLC Has $35,000 Stock Position in CME Group Inc. (NASDAQ:CME)

Crewe Advisors LLC lowered its position in shares of CME Group Inc. (NASDAQ:CMEFree Report) by 72.1% in the fourth quarter, HoldingsChannel reports. The fund owned 150 shares of the financial services provider’s stock after selling 387 shares during the period. Crewe Advisors LLC’s holdings in CME Group were worth $35,000 as of its most recent SEC filing.

A number of other large investors have also recently bought and sold shares of the company. Truvestments Capital LLC bought a new stake in shares of CME Group during the 3rd quarter worth approximately $26,000. SJS Investment Consulting Inc. raised its stake in shares of CME Group by 570.6% during the 4th quarter. SJS Investment Consulting Inc. now owns 114 shares of the financial services provider’s stock worth $26,000 after purchasing an additional 97 shares in the last quarter. Dunhill Financial LLC raised its stake in shares of CME Group by 188.4% during the 3rd quarter. Dunhill Financial LLC now owns 124 shares of the financial services provider’s stock worth $27,000 after purchasing an additional 81 shares in the last quarter. Financial Life Planners bought a new stake in shares of CME Group during the 4th quarter worth approximately $32,000. Finally, Fortitude Family Office LLC raised its stake in shares of CME Group by 120.3% during the 4th quarter. Fortitude Family Office LLC now owns 152 shares of the financial services provider’s stock worth $35,000 after purchasing an additional 83 shares in the last quarter. Institutional investors and hedge funds own 87.75% of the company’s stock.

CME Group Stock Up 1.1 %

CME opened at $244.41 on Friday. CME Group Inc. has a fifty-two week low of $190.70 and a fifty-two week high of $249.02. The company has a debt-to-equity ratio of 0.09, a quick ratio of 1.02 and a current ratio of 1.02. The company has a market capitalization of $88.08 billion, a P/E ratio of 25.70, a P/E/G ratio of 5.37 and a beta of 0.57. The stock has a fifty day moving average of $235.20 and a 200-day moving average of $223.49.

CME Group declared that its Board of Directors has approved a share buyback program on Thursday, December 5th that authorizes the company to repurchase $3.00 billion in outstanding shares. This repurchase authorization authorizes the financial services provider to buy up to 3.4% of its stock through open market purchases. Stock repurchase programs are usually a sign that the company’s board believes its shares are undervalued.

CME Group Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, March 26th. Investors of record on Friday, March 7th will be given a $1.25 dividend. This represents a $5.00 dividend on an annualized basis and a dividend yield of 2.05%. This is a boost from CME Group’s previous quarterly dividend of $1.15. CME Group’s dividend payout ratio (DPR) is presently 48.37%.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently weighed in on the company. Barclays increased their price target on CME Group from $231.00 to $257.00 and gave the company an “equal weight” rating in a research note on Monday, December 9th. Morgan Stanley increased their price target on CME Group from $210.00 to $233.00 and gave the company an “equal weight” rating in a research note on Thursday, October 17th. Piper Sandler increased their price target on CME Group from $250.00 to $258.00 and gave the company an “overweight” rating in a research note on Tuesday, January 7th. Citigroup cut CME Group from a “buy” rating to a “neutral” rating and dropped their price target for the company from $255.00 to $250.00 in a research note on Monday, January 6th. Finally, Oppenheimer increased their price target on CME Group from $245.00 to $258.00 and gave the company an “outperform” rating in a research note on Thursday, October 24th. Four research analysts have rated the stock with a sell rating, eight have assigned a hold rating and three have given a buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Hold” and an average target price of $229.27.

View Our Latest Research Report on CME

About CME Group

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Featured Stories

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CMEFree Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.